消化管間質腫瘍（GIST）の世界市場（～2026年）

• 英文タイトル：Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12010
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は消化管間質腫瘍（GIST）のグローバル市場について調査・分析したレポートです。種類別（胃、小腸、その他）市場規模、用途別（病院、クリニック、専門がん治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別消化管間質腫瘍（GIST）の競争状況、市場シェア
・世界の消化管間質腫瘍（GIST）市場：種類別市場規模 2015年-2020年（胃、小腸、その他）
・世界の消化管間質腫瘍（GIST）市場：種類別市場規模予測 2021年-2026年（胃、小腸、その他）
・世界の消化管間質腫瘍（GIST）市場：用途別市場規模 2015年-2020年（病院、クリニック、専門がん治療センター、その他）
・世界の消化管間質腫瘍（GIST）市場：用途別市場規模予測 2021年-2026年（病院、クリニック、専門がん治療センター、その他）
・北米の消化管間質腫瘍（GIST）市場分析：米国、カナダ
・ヨーロッパの消化管間質腫瘍（GIST）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの消化管間質腫瘍（GIST）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の消化管間質腫瘍（GIST）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの消化管間質腫瘍（GIST）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Sun Pharmaceutical、Pfizer、Bayer Aktiengesellschaft、NATCO Pharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.

Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Market
The global Gastrointestinal Stromal Tumor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Gastrointestinal Stromal Tumor Scope and Market Size
Gastrointestinal Stromal Tumor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma
…

Market segment by Type, the product can be split into
Stomach
Small Intestine
Others
Market segment by Application, split into
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Stomach
1.4.3 Small Intestine
1.4.4 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Specialized Cancer Treatment Centers
1.5.5 Other End Users
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2015-2026)
2.2 Global Gastrointestinal Stromal Tumor Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastrointestinal Stromal Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gastrointestinal Stromal Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Gastrointestinal Stromal Tumor Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Market Size
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2015-2020)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.2.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2019
3.3 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
3.4 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
3.5 Date of Enter into Gastrointestinal Stromal Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2015-2020)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2015-2020)
6.2 Gastrointestinal Stromal Tumor Key Players in North America (2019-2020)
6.3 North America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2015-2020)
7.2 Gastrointestinal Stromal Tumor Key Players in Europe (2019-2020)
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

8 China
8.1 China Gastrointestinal Stromal Tumor Market Size (2015-2020)
8.2 Gastrointestinal Stromal Tumor Key Players in China (2019-2020)
8.3 China Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
8.4 China Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gastrointestinal Stromal Tumor Market Size (2015-2020)
9.2 Gastrointestinal Stromal Tumor Key Players in Japan (2019-2020)
9.3 Japan Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
9.4 Japan Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gastrointestinal Stromal Tumor Market Size (2015-2020)
10.2 Gastrointestinal Stromal Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

11 India
11.1 India Gastrointestinal Stromal Tumor Market Size (2015-2020)
11.2 Gastrointestinal Stromal Tumor Key Players in India (2019-2020)
11.3 India Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
11.4 India Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gastrointestinal Stromal Tumor Market Size (2015-2020)
12.2 Gastrointestinal Stromal Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020)
12.4 Central & South America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
13.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Details
13.2.2 Sun Pharmaceutical Business Overview
13.2.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
13.2.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
13.2.5 Sun Pharmaceutical Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
13.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Bayer Aktiengesellschaft
13.4.1 Bayer Aktiengesellschaft Company Details
13.4.2 Bayer Aktiengesellschaft Business Overview
13.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
13.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
13.4.5 Bayer Aktiengesellschaft Recent Development
13.5 NATCO Pharma
13.5.1 NATCO Pharma Company Details
13.5.2 NATCO Pharma Business Overview
13.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
13.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2015-2020)
13.5.5 NATCO Pharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Gastrointestinal Stromal Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
Table 3. Ranking of Global Top Gastrointestinal Stromal Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stomach
Table 6. Key Players of Small Intestine
Table 7. Key Players of Others
Table 8. Global Gastrointestinal Stromal Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gastrointestinal Stromal Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gastrointestinal Stromal Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Market Share by Regions (2015-2020)
Table 12. Global Gastrointestinal Stromal Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Gastrointestinal Stromal Tumor Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Gastrointestinal Stromal Tumor Market Growth Strategy
Table 18. Main Points Interviewed from Key Gastrointestinal Stromal Tumor Players
Table 19. Global Gastrointestinal Stromal Tumor Revenue by Players (2015-2020) (Million US$)
Table 20. Global Gastrointestinal Stromal Tumor Market Share by Players (2015-2020)
Table 21. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2019)
Table 22. Global Gastrointestinal Stromal Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Gastrointestinal Stromal Tumor Product Solution and Service
Table 25. Date of Enter into Gastrointestinal Stromal Tumor Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 28. Global Gastrointestinal Stromal Tumor Market Size Share by Type (2015-2020)
Table 29. Global Gastrointestinal Stromal Tumor Revenue Market Share by Type (2021-2026)
Table 30. Global Gastrointestinal Stromal Tumor Market Size Share by Application (2015-2020)
Table 31. Global Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 32. Global Gastrointestinal Stromal Tumor Market Size Share by Application (2021-2026)
Table 33. North America Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 35. North America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 36. North America Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 37. North America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 38. North America Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 39. Europe Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 41. Europe Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 43. Europe Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 45. China Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 46. China Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 47. China Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 48. China Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 49. China Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 50. China Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 51. Japan Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 53. Japan Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 55. Japan Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 59. Southeast Asia Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 61. Southeast Asia Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 63. India Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 64. India Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 65. India Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 66. India Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 67. India Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 68. India Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Gastrointestinal Stromal Tumor Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Gastrointestinal Stromal Tumor Market Share (2019-2020)
Table 71. Central & South America Gastrointestinal Stromal Tumor Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Gastrointestinal Stromal Tumor Market Share by Type (2015-2020)
Table 73. Central & South America Gastrointestinal Stromal Tumor Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Gastrointestinal Stromal Tumor Market Share by Application (2015-2020)
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Product
Table 78. Novartis Revenue in Gastrointestinal Stromal Tumor Business (2015-2020) (Million US$)
Table 79. Novartis Recent Development
Table 80. Sun Pharmaceutical Company Details
Table 81. Sun Pharmaceutical Business Overview
Table 82. Sun Pharmaceutical Product
Table 83. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2015-2020) (Million US$)
Table 84. Sun Pharmaceutical Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Bayer Aktiengesellschaft Company Details
Table 91. Bayer Aktiengesellschaft Business Overview
Table 92. Bayer Aktiengesellschaft Product
Table 93. Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2015-2020) (Million US$)
Table 94. Bayer Aktiengesellschaft Recent Development
Table 95. NATCO Pharma Company Details
Table 96. NATCO Pharma Business Overview
Table 97. NATCO Pharma Product
Table 98. NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2015-2020) (Million US$)
Table 99. NATCO Pharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Market Share by Type: 2020 VS 2026
Figure 2. Stomach Features
Figure 3. Small Intestine Features
Figure 4. Others Features
Figure 5. Global Gastrointestinal Stromal Tumor Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Specialized Cancer Treatment Centers Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Gastrointestinal Stromal Tumor Report Years Considered
Figure 11. Global Gastrointestinal Stromal Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Gastrointestinal Stromal Tumor Market Share by Regions: 2020 VS 2026
Figure 13. Global Gastrointestinal Stromal Tumor Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Gastrointestinal Stromal Tumor Market Share by Players in 2019
Figure 16. Global Top Gastrointestinal Stromal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Revenue in 2019
Figure 18. North America Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Gastrointestinal Stromal Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

消化管間質腫瘍（GIST）治療薬の世界市場（～2026年）

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insights and Forecast to 2026
MRC2-11QY06723 2020年11月20日 148Pages
当調査資料は消化管間質腫瘍（GIST）治療薬のグローバル市場について調査・分析したレポートです。種類別（アンカセルチブ、塩酸アナグレリドCR、APG-1351、ビニメチニブ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

消化管間質腫瘍（GIST）治療の世界市場（～2026年）

Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12011 2020年11月25日 98Pages
当調査資料は消化管間質腫瘍（GIST）治療のグローバル市場について調査・分析したレポートです。種類別（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他）市場規模、用途別（病院、クリニック、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

性腺性腺間質腫瘍治療の世界市場（～2026年）

Global Sex Cord Gonadal Stromal Tumor Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04596 2020年11月20日 94Pages
当調査資料は性腺性腺間質腫瘍治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、手術、その他）市場規模、用途別（病院、診療所、がん研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

性腺性腺間質腫瘍の世界市場（～2026年）

Global Sex Cord Gonadal Stromal Tumor Market Size, Status and Forecast 2020-2026
MRC2-11QY04595 2020年11月20日 127Pages
当調査資料は性腺性腺間質腫瘍のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院用、診療所用、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

腫瘍治療フィールド（TTField）の世界市場（～2026年）

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2020-2026
MRC2-11QY04908 2020年11月20日 90Pages
当調査資料は腫瘍治療フィールド（TTField）のグローバル市場について調査・分析したレポートです。種類別（低周波、中周波）市場規模、用途別（病院、診療所、がん・放射線治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

間質血管画分の世界市場（～2026年）

Global Stromal Vascular Fraction Market Size, Status and Forecast 2020-2026
MRC2-11QY04746 2020年11月20日 92Pages
当調査資料は間質血管画分のグローバル市場について調査・分析したレポートです。種類別（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品）市場規模、用途別（病院、専門クリニック、幹細胞バンク/研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨー...

循環腫瘍細胞（CTC）の世界市場（～2026年）

Global Circulating Tumor Cell Market Size, Status and Forecast 2020-2026
MRC2-11QY11378 2020年11月25日 130Pages
当調査資料は循環腫瘍細胞（CTC）のグローバル市場について調査・分析したレポートです。種類別（CTCエンリッチメント、CTC検出、CTC分析）市場規模、用途別（乳がん、前立腺がん、大腸がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

間質細胞由来因子1の世界市場（～2026年）

Global Stromal Cell Derived Factor 1 Market Insights and Forecast to 2026
MRC2-11QY10220 2020年11月25日 116Pages
当調査資料は間質細胞由来因子1のグローバル市場について調査・分析したレポートです。種類別（131-H12、1143-H1、ドシパルスタットナトリウム、ゲニステイン、その他）市場規模、用途別（冠状動脈疾患、重症下肢虚血、原発性免疫不全、脳卒中、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

胃腸装置の世界市場（～2026年）

Global Gastrointestinal Devices Market Size, Status and Forecast 2020-2026
MRC2-11QY12007 2020年11月25日 98Pages
当調査資料は胃腸装置のグローバル市場について調査・分析したレポートです。種類別（胃腸内視鏡、胃腸ステント留置、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

ペプチド胃腸障害治療薬の世界市場（～2026年）

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04205 2020年11月20日 91Pages
当調査資料はペプチド胃腸障害治療薬のグローバル市場について調査・分析したレポートです。種類別（テデュグルチド、リナクロチド、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

消化管間質腫瘍（GIST）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Stromal Tumor (GIST) Drug Market The global Gastrointestinal Stromal Tumor (GIST) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Stromal Tumo…
消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
性腺性腺間質腫瘍治療の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market The global Sex Cord Gonadal Strom…
性腺性腺間質腫瘍の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, …
交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…